Hrt Financial LP Annexon, Inc. Transaction History

Hrt Financial LP

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 09, 2024	BUY	$1.63 - $4.63 $19,579 - $55,615	12,012 New	12,012 $54,000
Q1 2023 May 12, 2023	BUY	$3.74 - $7.46 $425,638 - $849,000	113,807 New	113,807 $438,000
Q2 2022 Aug 12, 2022	SELL	$2.11 - $4.06 $270,449 - $520,390	-128,175 Closed	0 $0
Q1 2022 May 16, 2022	BUY	$2.73 - $11.94 $311,334 - $1.36 Million	114,042 Added 806.92%	128,175 $349,000
Q4 2021 Feb 14, 2022	BUY	$11.49 - $22.0 $162,388 - $310,926	14,133 New	14,133 $162,000
Q2 2021 Aug 16, 2021	SELL	$17.81 - $27.48 $134,251 - $207,144	-7,538 Closed	0 $0
Q1 2021 May 17, 2021	BUY	$22.0 - $35.01 $165,836 - $263,905	7,538 New	7,538 $209,000

156

101M

3.73M

1.3M

Ticker ANNX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 47,617,700
Market Cap $335M
Description
Annexon, Inc., a clinical-stage biopharmaceutical company, discovers and develops therapeutics for autoimmune, neurodegenerative, and ophthalmic disorders. The company's C1q is an initiating molecule of the classical complement pathway that targets distinct disease processes, such as antibody-mediated autoimmune disease and complement-mediated n...

Get notified when there are updates to the investment portfolio of Hrt Financial LP, based on Form 13F filings with the SEC.

Stay updated on Hrt Financial LP with notifications on news.